
Artelo Biosciences, Inc. Common Stock
ARTL
ARTL: Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors and neurotransmitters that form a biochemical communication network in body. It is focused on discovering, licensing, developing and commercializing treatments that control endocannabinoid system. The company pursues technologies and programs that offer proprietary approaches to cannabinoid-based therapies, also those derived from the cannabis plant and synthetic cannabinoids, as well as new chemical entities and compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare and orphan disease.
moreShow ARTL Financials
Recent trades of ARTL by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ARTL's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on ARTL's company Twitter account
Number of mentions of ARTL in WallStreetBets Daily Discussion
Recent insights relating to ARTL
Recent picks made for ARTL stock on CNBC
ETFs with the largest estimated holdings in ARTL
Flights by private jets registered to ARTL